All products / DC47763
CAT. NO. DC47763
Vevorisertib trihydrochloride
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $800 USDRequest a quote / confirm availability → |
| 250 mg | $1,450 USDRequest a quote / confirm availability → |
| 1 g | $2,900 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
Vevorisertib (ARQ 751) (trihydrochloride) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). Vevorisertib (trihydrochloride), as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC47763 |
|---|---|
| Product name | Vevorisertib trihydrochloride |
| CAS | 1416775-08-0 |
| Molecular formula | C35H41Cl3N8O |
| Molecular weight | 696.1 |
| Purity | >98% |
| SMILES | CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1.Cl.Cl.Cl |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Vevorisertib trihydrochloride (DC47763)